Targeted biologics and multidisciplinary care are reshaping the management of patients with thyroid eye disease. But who should be leading this care and how? Medscape would like to hear from you about how often you see TED, your biggest clinical challenges, and which treatments you rely on most.
Medscape Reader Polls